FDA Advisory Panel Unanimously Recommends Approval of Spark Therapeutics’ Gene Therapy Luxturna – Genetic Engineering & Biotechnology News
|
FDA Advisory Panel Unanimously Recommends Approval of Spark Therapeutics' Gene Therapy Luxturna
Genetic Engineering & Biotechnology News Spark Therapeutics is on track to win FDA approval later this year to market the first gene therapy ever authorized to treat an inherited disease in the U.S., following an advisory committee's unanimous recommendation yesterday in favor of the company … |
